CGP 70726
Latest Information Update: 31 Jul 1998
At a glance
- Originator Novartis
- Class Antivirals
- Mechanism of Action HIV protease inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 31 Jul 1998 No-Development-Reported for HIV infections treatment in Switzerland (PO)
- 14 Nov 1996 New profile
- 14 Nov 1996 Preclinical development for HIV infections treatment in Switzerland (PO)